⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for d816v

Every month we try and update this database with for d816v cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Masitinib in Patients With Mastocytosis With Handicap and Bearing the D816V MutationNCT01266369
Mastocytosis
masitinib
18 Years - AB Science
(Apex) Bezuclastinib in Patients With Advanced Systemic MastocytosisNCT04996875
Advanced System...
SM With an Asso...
Mast Cell Leuke...
Aggressive Syst...
bezuclastinib
18 Years - Cogent Biosciences, Inc.
(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic MastocytosisNCT05186753
SSM
Mastocytosis, I...
Mastocytosis, S...
Mastocytosis
Bezuclastinib T...
Bezuclastinib T...
Placebo Tablets
18 Years - Cogent Biosciences, Inc.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: